Takeda's Ninlaro gets FDA approval to treat multiple myeloma
Takeda Pharmaceutical has received approval from the US Food and Drug Administration (FDA) for Ninlaro (ixazomib) capsules in combination with lenalidomide and dexamethasone to treat patients with multiple myeloma who have received at least one prior…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Dexamethasone | Food and Drug Administration (FDA) | Myeloma | Pharmaceuticals | Revlimid